Published :
Tables : 43
Figures : 42
Category : Healthcare
No. of Pages : 205
Report Code : HC-1261
Peripheral Vascular Devices Market is estimated to register a CAGR of over 6.3% during the forecast period 2022 to 2028. Peripheral arterial disease (PAD) is caused by blocking or narrowing of the blood vessels owing to the build-up of plaque. This condition can result in aneurysms, kidney diseases, the death of tissue, heart stroke in cases when left untreated. As per the National Institute of Health, one in concerning people over 50 years, one in every 20 American has PAD. It has influenced over eight to 12 million people in the U.S, particularly to those over the age of 50. As the population is constantly increasing, the incidences of disease are rising which could proliferate from over 10 million to reach an overall of 20 million worldwide by 2050. With the ageing of the population around the world, it possibly seems that PAD will be normalised in the upcoming years. Therefore, as per the statistics have revealed, the number of peripheral arterial disease is rising at a quicker pace, which is gradually driving the peripheral vascular devices market. Other factors like the growing demand for minimally-invasive surgeries for peripheral arterial disease, in particular, lifestyle changes, technological advancements and increase in the geriatric population have expanded the market size. Based on type, the peripheral vascular devices market is bifurcated into embolic projection devices, peripheral guidewires, peripheral stents grafts, peripheral venous thrombectomy device, vena cava filters, angioplasty catheters and PTA balloons. Peripheral vascular stents graft accounts for the largest market share. Angioplasty catheter segment is predicted to showcase substantial growth over the forecast period. Geographically, the market is fragmented into North America, Europe, Asia Pacific and the rest of the world. North America dominates the peripheral vascular devices market which is followed by the Europe region. The Asia Pacific region is anticipated to proliferate during the forecast period owing to the increasing prevalence of peripheral vascular diseases. Manufacturers of peripheral vascular devices are slowly adopting integral developmental strategies to create innovative devices. Many clinical trials are currently in progress to increase device efficacy and safety. Key market players in the peripheral vascular devices market are Medtronic, Becton, Dickinson and Company, Terumo Corporation, Boston Scientific Corporation, Abbott, Cardinal Health, iVascular, B. Braun Melsungen, Biosensors International Group, Biotronik SE & Co. KG, Penumbra Inc. Peripheral Vascular Devices Market Segmentation: By Product • Angioplasty Balloons o Old/Normal Balloons o Drug-eluting Balloons o Cutting and Scoring Balloons • Angioplasty Stents o Drug-eluting Stents o Bare-metal Stents • Self-expandable Stents • Balloon-expandable Stents • Catheters o Angiography Catheters o Guiding Catheters o IVUS/OCT Catheters • EVAR Stent Grafts o Abdominal Aortic Aneurysm Stent Grafts o Thoracic Aortic Aneurysm Stent Grafts • Inferior Vena Cava Filters o Retrievable Filters o Permanent Filters • Plaque Modification Devices o Atherectomy Devices o Thrombectomy Devices • Hemodynamic Flow Alteration Devices o Embolic Protection Devices o Chronic Total Occlusion Devices • Other Devices o Guidewires o Vascular Closure Devices o Introducer Sheaths o Balloon Inflation Devices By Region • North America • Latin America • Europe • Asia Pacific • Middle East and Africa Peripheral Vascular Devices Market Video Sample: Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Invisible Braces Market By Product and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Peripheral arterial disease (PAD) is caused by blocking or narrowing of the blood vessels owing to the build-up of plaque. This condition can result in aneurysms, kidney diseases, the death of tissue, heart stroke in cases when left untreated. As per the National Institute of Health, one in concerning people over 50 years, one in every 20 American has PAD. It has influenced over eight to 12 million people in the U.S, particularly to those over the age of 50.
As the population is constantly increasing, the incidences of disease are rising which could proliferate from over 10 million to reach an overall of 20 million worldwide by 2050. With the ageing of the population around the world, it possibly seems that PAD will be normalised in the upcoming years. Therefore, as per the statistics have revealed, the number of peripheral arterial disease is rising at a quicker pace, which is gradually driving the peripheral vascular devices market. Other factors like the growing demand for minimally-invasive surgeries for peripheral arterial disease, in particular, lifestyle changes, technological advancements and increase in the geriatric population have expanded the market size.
Based on type, the peripheral vascular devices market is bifurcated into embolic projection devices, peripheral guidewires, peripheral stents grafts, peripheral venous thrombectomy device, vena cava filters, angioplasty catheters and PTA balloons. Peripheral vascular stents graft accounts for the largest market share. Angioplasty catheter segment is predicted to showcase substantial growth over the forecast period.
Geographically, the market is fragmented into North America, Europe, Asia Pacific and the rest of the world. North America dominates the peripheral vascular devices market which is followed by the Europe region. The Asia Pacific region is anticipated to proliferate during the forecast period owing to the increasing prevalence of peripheral vascular diseases. Manufacturers of peripheral vascular devices are slowly adopting integral developmental strategies to create innovative devices. Many clinical trials are currently in progress to increase device efficacy and safety.
Key market players in the peripheral vascular devices market are Medtronic, Becton, Dickinson and Company, Terumo Corporation, Boston Scientific Corporation, Abbott, Cardinal Health, iVascular, B. Braun Melsungen, Biosensors International Group, Biotronik SE & Co. KG, Penumbra Inc.
Peripheral Vascular Devices Market Segmentation:
By Product • Angioplasty Balloons o Old/Normal Balloons o Drug-eluting Balloons o Cutting and Scoring Balloons • Angioplasty Stents o Drug-eluting Stents o Bare-metal Stents • Self-expandable Stents • Balloon-expandable Stents • Catheters o Angiography Catheters o Guiding Catheters o IVUS/OCT Catheters • EVAR Stent Grafts o Abdominal Aortic Aneurysm Stent Grafts o Thoracic Aortic Aneurysm Stent Grafts • Inferior Vena Cava Filters o Retrievable Filters o Permanent Filters • Plaque Modification Devices o Atherectomy Devices o Thrombectomy Devices • Hemodynamic Flow Alteration Devices o Embolic Protection Devices o Chronic Total Occlusion Devices • Other Devices o Guidewires o Vascular Closure Devices o Introducer Sheaths o Balloon Inflation Devices
By Region
• North America • Latin America • Europe • Asia Pacific • Middle East and Africa
Peripheral Vascular Devices Market Video Sample:
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the Invisible Braces Market By Product and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Peripheral Vascular Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Peripheral Vascular Devices Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Peripheral Vascular Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Peripheral Vascular Devices Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Angioplasty Balloons 7.1.1. Old/Normal Balloons 7.1.2. Drug-eluting Balloons 7.1.3. Cutting and Scoring Balloons 7.2. Angioplasty Stents 7.2.1. Drug-eluting Stents 7.2.2. Bare-metal Stents 7.2.2.1. Self-expandable Stents 7.2.2.2. Balloon-expandable Stents 7.3. Catheters 7.3.1. Angiography Catheters 7.3.2. Guiding Catheters 7.3.3. IVUS/OCT Catheters 7.4. EVAR Stent Grafts 7.4.1. Abdominal Aortic Aneurysm Stent Grafts 7.4.2. Thoracic Aortic Aneurysm Stent Grafts 7.5. Inferior Vena Cava Filters 7.5.1. Retrievable Filters 7.5.2. Permanent Filters 7.6. Plaque Modification Devices 7.6.1. Atherectomy Devices 7.6.2. Thrombectomy Devices 7.7. Hemodynamic Flow Alteration Devices 7.7.1. Embolic Protection Devices 7.7.2. Chronic Total Occlusion Devices 7.8. Other Devices 7.8.1. Guidewires 7.8.2. Vascular Closure Devices 7.8.3. Introducer Sheaths 7.8.4. Balloon Inflation Devices 8. North America Peripheral Vascular Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 8.1. Introduction 8.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 8.2.1. U.S.A 8.2.2. Canada 8.2.3. Mexico 8.3. Market Size (USD Million) Forecast for North America 2022-2028 9. Latin America Peripheral Vascular Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. Brazil 9.2.2. Venezuela 9.2.3. Argentina 9.2.4. Rest of Latin America 9.3. Market Size (USD Million) Forecast for Latin America 2022-2028 10. Europe Peripheral Vascular Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Russia 10.2.7. Poland 10.2.7. Rest of Europe 10.3. Market Size (USD Million) Forecast for Europe 2022-2028 11. Asia Pacific Peripheral Vascular Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Japan 11.2.2. China 11.2.3. India 11.2.4. Australia and New Zealand 11.2.5. ASEAN 11.2.6. Rest of Asia Pacific 11.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 12. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. GCC 12.2.2. Israel 12.2.3. South Africa 12.2.4. Rest of MEA 12.3. Market Size (USD Million) Forecast for MEA 2022-2028 13. Market Share Analysis and Competitive Landscape 13.1. Global Landscape - Key Players, Revenue and Presence 13.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 13.3. Global Emerging Companies 13.4. North America - Market Share Analysis and Key Regional Players 13.5. Europe - Market Share Analysis and Key Regional Players 13.6. Asia Pacific - Market Share Analysis and Key Regional Players 13.7. Global Key Player - Growth Matrix 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 14.1. Medtronic 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Becton, Dickinson and Company 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Terumo Corporation 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Boston Scientific Corporation 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Abbott 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Cardinal Health 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. iVascular 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. B. Braun Melsungen 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. Biosensors International Group 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10.Biotronik Se & Co. Kg 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11.Penumbra Inc. 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 15. Pre and Post COVID-19 Impact 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Peripheral Vascular Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Peripheral Vascular Devices Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Peripheral Vascular Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Peripheral Vascular Devices Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Angioplasty Balloons 7.1.1. Old/Normal Balloons 7.1.2. Drug-eluting Balloons 7.1.3. Cutting and Scoring Balloons 7.2. Angioplasty Stents 7.2.1. Drug-eluting Stents 7.2.2. Bare-metal Stents 7.2.2.1. Self-expandable Stents 7.2.2.2. Balloon-expandable Stents 7.3. Catheters 7.3.1. Angiography Catheters 7.3.2. Guiding Catheters 7.3.3. IVUS/OCT Catheters 7.4. EVAR Stent Grafts 7.4.1. Abdominal Aortic Aneurysm Stent Grafts 7.4.2. Thoracic Aortic Aneurysm Stent Grafts 7.5. Inferior Vena Cava Filters 7.5.1. Retrievable Filters 7.5.2. Permanent Filters 7.6. Plaque Modification Devices 7.6.1. Atherectomy Devices 7.6.2. Thrombectomy Devices 7.7. Hemodynamic Flow Alteration Devices 7.7.1. Embolic Protection Devices 7.7.2. Chronic Total Occlusion Devices 7.8. Other Devices 7.8.1. Guidewires 7.8.2. Vascular Closure Devices 7.8.3. Introducer Sheaths 7.8.4. Balloon Inflation Devices
8. North America Peripheral Vascular Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 8.1. Introduction 8.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 8.2.1. U.S.A 8.2.2. Canada 8.2.3. Mexico 8.3. Market Size (USD Million) Forecast for North America 2022-2028
9. Latin America Peripheral Vascular Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. Brazil 9.2.2. Venezuela 9.2.3. Argentina 9.2.4. Rest of Latin America 9.3. Market Size (USD Million) Forecast for Latin America 2022-2028
10. Europe Peripheral Vascular Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Russia 10.2.7. Poland 10.2.7. Rest of Europe 10.3. Market Size (USD Million) Forecast for Europe 2022-2028
11. Asia Pacific Peripheral Vascular Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Japan 11.2.2. China 11.2.3. India 11.2.4. Australia and New Zealand 11.2.5. ASEAN 11.2.6. Rest of Asia Pacific 11.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
12. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. GCC 12.2.2. Israel 12.2.3. South Africa 12.2.4. Rest of MEA 12.3. Market Size (USD Million) Forecast for MEA 2022-2028
13. Market Share Analysis and Competitive Landscape 13.1. Global Landscape - Key Players, Revenue and Presence 13.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 13.3. Global Emerging Companies 13.4. North America - Market Share Analysis and Key Regional Players 13.5. Europe - Market Share Analysis and Key Regional Players 13.6. Asia Pacific - Market Share Analysis and Key Regional Players 13.7. Global Key Player - Growth Matrix
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 14.1. Medtronic 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Becton, Dickinson and Company 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Terumo Corporation 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Boston Scientific Corporation 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Abbott 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Cardinal Health 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. iVascular 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. B. Braun Melsungen 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. Biosensors International Group 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10.Biotronik Se & Co. Kg 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11.Penumbra Inc. 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview
15. Pre and Post COVID-19 Impact 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations
16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics